L3MBTL4 methylation is a sensitive marker of DNA-PK inhibitor in pancreatic cancer
Y Yao(Chinese PLA General Hospital), Mingzhou Guo(Chinese PLA General Hospital), Meiying Zhang(Chinese PLA General Hospital), Yuan Li(Chinese PLA General Hospital), Yazhuo Li(Chinese PLA General Hospital), Cheng Zhu(Chinese PLA General Hospital), Xiaomo Su(Chinese PLA General Hospital), Ruijie Wang(Chinese PLA General Hospital), Aiai Gao(Chinese PLA General Hospital)
Cited by 0
Related Papers
Epigenetic heterogeneity in cancer
|Biomarker Research|2019|278
Methylation of ZNF331 is an independent prognostic marker of colorectal cancer and promotes colorectal cancer growth
|Clinical Epigenetics|2017|98
The clinical value of aberrant epigenetic changes of DNA damage repair genes in human cancer
|Oncotarget|2016|93
MicroRNA-155 Is Involved in the Pathogenesis of Ulcerative Colitis by Targeting FOXO3a
|Inflammatory Bowel Diseases|2014|89
Exploring the Effects of Different Types of Surfactants on Zebrafish Embryos and Larvae
|Scientific Reports|2015|88